Surgery and chemotherapy are associated with improved overall survival in anal adenocarcinoma: results of a national cohort study.

AAC tumors have worse prognosis than either RAC or ASCC. Within patients with AAC, nonsurgical management was independently associated with increased mortality hazard. Patients with AAC should be evaluated in a multidisciplinary setting and referred for surgery.